{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:26:24Z","timestamp":1789539984149,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:p>Monitoring viral load among patients receiving antiretroviral therapy (ART) is essential to detecting treatment failures, drug resistance, and inappropriate changes to second-line treatment regimens. Determinants of virological failure (VF) among human immunodeficiency virus patients has been scarcely studied in the current study area. Therefore this study aimed to determine the factors that contribute to determinants of virological failure among people living with human immunodeficiency virus receiving first-line ART in Hiwot Fana Comprehensive University Hospital, Eastern Ethiopia. A case\u2013control study was conducted from November 28 to December 11, 2022. We recruited all 246 eligible cases (patients with a viral load of &gt;1000 copies\/mL) and randomly selected 246 control patients (viral load \u22641000 copies\/mL). Data were extracted from the patient\u2019s medical records, including their ART intake, registration, and follow-up details. We employed binary logistic regression to fit both bivariable and multivariable models, and then statistical significance was declared at a <jats:italic toggle=\"yes\">P<\/jats:italic>-value of \u2264.05. This study showed that age under 35 years (AOR\u2005=\u20051.99, 95%CI: 1.22, 3.25), CD4 count of &lt;200 cells\/mm<jats:sup>3<\/jats:sup> (AOR\u2005=\u20056.46, 95% CI: 3.19, 13.09) or 200\u2013499 cells\/mm<jats:sup>3<\/jats:sup> (AOR\u2005=\u20052.44, 95% CI: 1.37, 4.35), World Health Organization clinical stage II (AOR\u2005=\u20056.57, 95% CI: 3.72, 11.62) or III (AOR\u2005=\u20054.54, 95% CI: 1.41, 14.58), opportunistic infections (AOR\u2005=\u20055.03, 95% CI: 2.02, 12.50), poor adherence to treatment (AOR\u2005=\u20056.38, 95% CI: 2.64, 15.39), and duration on ART for 48 months (AOR\u2005=\u20058.27, 95% CI: 3.03, 21.13) had higher odds of virologic failure compared to their counterparts. Poor adherence to therapy, longer ART duration, younger age, a low baseline CD4 count, clinical stages II or III, and the presence of opportunistic infection had a significant impact on VF. Adherence counseling and careful monitoring of patients are required to ensure sufficient suppression of viral load.<\/jats:p>","DOI":"10.1097\/md.0000000000043255","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T09:00:17Z","timestamp":1753952417000},"page":"e43255","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Determinants of virological failure among people living with HIV receiving first-line antiretroviral therapy in Hiwot Fana Comprehensive University Hospital, Eastern Ethiopia"],"prefix":"10.1097","volume":"104","author":[{"given":"Kedir","family":"Nuredin","sequence":"first","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitsum","family":"Weldegebreal","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia"},{"name":"Laboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-3227","authenticated-orcid":false,"given":"Firayad","family":"Ayele","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fekede","family":"Asefa","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia"},{"name":"Department of Pediatrics, College of Medicine, The University of Tennessee Health Science Center (UTHSC) \u2013 Oak Ridge National Laboratory (ORNL) Center for Biomedical Informatics, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251014","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra1011874","article-title":"Acute HIV-1 infection.","volume":"364","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20251014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S0950268817003016","article-title":"Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.","volume":"146","author":"Song","year":"2018","journal-title":"Epidemiol Infect"},{"key":"R6-20251014","article-title":"Treatment & Care.","year":"2022"},{"key":"R7-20251014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","article-title":"Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society \u2013 USA Panel.","volume":"312","author":"G\u00fcnthard","year":"2014","journal-title":"JAMA"},{"key":"R10-20251014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.trstmh.2010.01.004","article-title":"Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?","volume":"104","author":"Zachariah","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R15-20251014","doi-asserted-by":"crossref","first-page":"e036223","DOI":"10.1136\/bmjopen-2019-036223","article-title":"Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case\u2013control study.","volume":"10","author":"Meshesha","year":"2020","journal-title":"BMJ Open"},{"key":"R21-20251014","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1468-1293.2010.00890.x","article-title":"Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.","volume":"12","author":"Cescon","year":"2011","journal-title":"HIV Med"},{"key":"R22-20251014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2428-3","article-title":"Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014\u2013July 2015.","volume":"17","author":"Bulage","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R24-20251014","doi-asserted-by":"crossref","first-page":"e036223","DOI":"10.1136\/bmjopen-2019-036223","article-title":"Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case\u2013control study.","volume":"10","author":"Meshesha","year":"2020","journal-title":"BMJ Open"},{"key":"R25-20251014","first-page":"697","article-title":"Determinants of virologic failure among adults on second line antiretroviral therapy in Wollo, Amhara Regional State, Northeast Ethiopia.","volume":"12","author":"Seid","year":"2020","journal-title":"HIV\/AIDS (Auckland, N.Z.)"},{"key":"R27-20251014","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/apc.2015.0139","article-title":"The HIV care cascade measured over time and by age, sex, and race in a large national integrated care system.","volume":"29","author":"Horberg","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"R29-20251014","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s10461-018-2055-z","article-title":"Psychiatric illness, substance use, and viral suppression among HIV-positive men of color who have sex with men in Los Angeles.","volume":"22","author":"Aralis","year":"2018","journal-title":"AIDS Behav"},{"key":"R30-20251014","doi-asserted-by":"crossref","first-page":"e005886","DOI":"10.1136\/bmjopen-2014-005886","article-title":"HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China.","volume":"4","author":"Leng","year":"2014","journal-title":"BMJ Open"},{"key":"R31-20251014","doi-asserted-by":"crossref","first-page":"e0171780","DOI":"10.1371\/journal.pone.0171780","article-title":"High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005\u20132015.","volume":"12","author":"Kyaw","year":"2017","journal-title":"PLoS One"},{"key":"R32-20251014","first-page":"931","article-title":"Determinants of virological failure among patients on first-line antiretroviral therapy in central Oromia, Ethiopia: a case\u2013control study.","volume":"12","author":"Abdullahi","year":"2020","journal-title":"HIV\/AIDS (Auckland, N.Z.)"},{"key":"R33-20251014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD 4+ T-cell depletion in HIV infection: mechanisms of immunological failure.","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol Rev"},{"key":"R34-20251014","doi-asserted-by":"crossref","first-page":"e82718","DOI":"10.1371\/journal.pone.0082718","article-title":"Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.","volume":"8","author":"Palladino","year":"2013","journal-title":"PLoS One"},{"key":"R35-20251014","first-page":"2017","article-title":"Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections.","volume":"8","author":"Vijayan","year":"2017","journal-title":"Front Immunol"},{"key":"R38-20251014","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/jac\/dkv143","article-title":"Determinants of virological failure and antiretroviral drug resistance in Mozambique.","volume":"70","author":"Rup\u00e9rez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R40-20251014","first-page":"44","article-title":"A brief history of antiretroviral therapy of HIV infection: success and challenges.","volume":"47","author":"Palmisano","year":"2011","journal-title":"Ann Ist Super Sanita"},{"key":"R41-20251014","doi-asserted-by":"crossref","first-page":"e0116144","DOI":"10.1371\/journal.pone.0116144","article-title":"Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.","volume":"10","author":"Jobanputra","year":"2015","journal-title":"PLoS One"},{"key":"R42-20251014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4314\/gmj.v55i2.3","article-title":"Determinants of viral load non-suppression among people living with HIV on antiretroviral therapy in Kumasi, Ghana.","volume":"55","author":"Ansah","year":"2021","journal-title":"Ghana Med J"},{"key":"R43-20251014","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s10461-022-03610-y","article-title":"Burden and associated factors of virological failure among people living with HIV in Sub-Saharan Africa: a systematic review and meta-analysis.","volume":"26","author":"Agegnehu","year":"2022","journal-title":"AIDS Behav"},{"key":"R44-20251014","first-page":"153","article-title":"Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case\u2013control study.","volume":"9","author":"Bayu","year":"2017","journal-title":"HIV\/AIDS (Auckland, N.Z.)"},{"key":"R46-20251014","doi-asserted-by":"crossref","first-page":"e0166661","DOI":"10.1371\/journal.pone.0166661","article-title":"Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China.","volume":"11","author":"Zuo","year":"2016","journal-title":"PLoS One"},{"key":"R47-20251014","doi-asserted-by":"crossref","first-page":"e0192077","DOI":"10.1371\/journal.pone.0192077","article-title":"Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.","volume":"13","author":"Jean Louis","year":"2018","journal-title":"PLoS One"},{"key":"R49-20251014","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0253-7613.96296","article-title":"Antiretroviral drugs: critical issues and recent advances.","volume":"44","author":"Desai","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"R50-20251014","first-page":"34","article-title":"Risk factors of clinical and immunological failure in South Indian cohort on generic antiretroviral therapy.","volume":"65","author":"Sadashiv","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"R51-20251014","first-page":"1","article-title":"Prevalence and determinants of virological failure among adult antiretroviral treatment experienced HIV-1 patients in South Omo, Ethiopia.","volume":"36","author":"Tachbele","year":"2022","journal-title":"Ethiop J Health Dev"},{"key":"R53-20251014","first-page":"1468","article-title":"Liposomes as carriers for the delivery of efavirenz in combination with glutathione \u2013 an approach to combat opportunistic infections.","volume":"12","author":"Kenchappa","year":"2022","journal-title":"Appl Sci (Basel, Switzerland)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:00:56Z","timestamp":1760461256000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":30,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043255","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}